John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs
A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.
by ·
A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.
by · Published April 8, 2021
by · Published June 21, 2021
by · Published May 31, 2021